Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Citi
Queensland Health
Express Scripts
AstraZeneca
Cantor Fitzgerald
Teva
Moodys
Boehringer Ingelheim

Generated: October 15, 2018

DrugPatentWatch Database Preview

Clinigen Hlthcare Company Profile

« Back to Dashboard

What is the competitive landscape for CLINIGEN HLTHCARE, and what generic alternatives to CLINIGEN HLTHCARE drugs are available?

CLINIGEN HLTHCARE has three approved drugs.

There is one US patent protecting CLINIGEN HLTHCARE drugs.

Summary for Clinigen Hlthcare
US Patents:1
Tradenames:3
Ingredients:3
NDAs:3

Drugs and US Patents for Clinigen Hlthcare

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Clinigen Hlthcare FOSCAVIR foscarnet sodium INJECTABLE;INJECTION 020068-001 Sep 27, 1991 RX Yes Yes ➤ Sign Up ➤ Sign Up
Clinigen Hlthcare TOTECT dexrazoxane hydrochloride INJECTABLE;INJECTION 022025-001 Sep 6, 2007 RX Yes Yes 6,727,253 ➤ Sign Up ➤ Sign Up
Clinigen Hlthcare ETHYOL amifostine INJECTABLE;INJECTION 020221-001 Dec 8, 1995 AP RX Yes Yes ➤ Sign Up ➤ Sign Up
Clinigen Hlthcare ETHYOL amifostine INJECTABLE;INJECTION 020221-002 Sep 10, 1999 DISCN No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Clinigen Hlthcare

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Clinigen Hlthcare ETHYOL amifostine INJECTABLE;INJECTION 020221-001 Dec 8, 1995 5,424,471 ➤ Sign Up
Clinigen Hlthcare ETHYOL amifostine INJECTABLE;INJECTION 020221-002 Sep 10, 1999 5,242,471 ➤ Sign Up
Clinigen Hlthcare FOSCAVIR foscarnet sodium INJECTABLE;INJECTION 020068-001 Sep 27, 1991 4,215,113 ➤ Sign Up
Clinigen Hlthcare FOSCAVIR foscarnet sodium INJECTABLE;INJECTION 020068-001 Sep 27, 1991 4,339,445 ➤ Sign Up
Clinigen Hlthcare ETHYOL amifostine INJECTABLE;INJECTION 020221-002 Sep 10, 1999 5,591,731 ➤ Sign Up
Clinigen Hlthcare ETHYOL amifostine INJECTABLE;INJECTION 020221-002 Sep 10, 1999 5,994,409 ➤ Sign Up
Clinigen Hlthcare ETHYOL amifostine INJECTABLE;INJECTION 020221-001 Dec 8, 1995 5,591,731 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for CLINIGEN HLTHCARE drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe For Injection 500 mg/vial ➤ Subscribe 2004-04-16

International Patents for Clinigen Hlthcare Drugs

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO) 0054782 ➤ Sign Up
Australia 769533 ➤ Sign Up
Hong Kong 1043054 ➤ Sign Up
Norway 20014433 ➤ Sign Up
Germany 1162981 ➤ Sign Up
European Patent Office 1459752 ➤ Sign Up
European Patent Office 1162981 ➤ Sign Up
Country Document Number Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Cipla
Fish and Richardson
Queensland Health
Covington
Cerilliant
Cantor Fitzgerald
AstraZeneca
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.